A patient with vCJD who showed “remarkable” improvement after a controversial
drug treatment has died after reportedly suffering liver damage. Rachel Forber
was diagnosed with the human form of mad cow disease in June. Two months later
she began a course of chlorpromazine, an antipsychotic, and quinacrine, which is
normally used against malaria. Laboratory tests suggested that both drugs can
block the formation of prions, which cause vCJD. “It’s terrible for hope to be
given and then snatched away like that. We’re right back where we started with
no cure,” says Francis Hall of Britain’s Human BSE Foundation. But authorities…
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
The race to understand how and when Thwaites glacier will collapse
2
Where, when and how to watch the 2026 solar eclipse
3
Our verdict on The Selfish Gene: An unpopular piece of popular science
4
Humans sleep the least of all apes – is it the secret to our success?
5
Babies are born with the neural foundations for maths
6
The best sci-fi novel in 2026 so far – plus 6 other great reads
7
US government wants to have a useful quantum computer by 2028
8
We’ve uncovered a master gene that switches on human development
9
Remote-controlled cockroach swarm can now breathe underwater
10
If you aren't terrified by this heatwave, you should be



